Wednesday, March 16, 2016

BRIEF-Cleveland BioLabs provides update on pre-EUA review of Entolimod as radiation countermeasure

* FDA indicated further review of pre-EUA dossier would not

proceed until bio-comparability data have been evaluated by

agency

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)